0KCS.L • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold 0KCS.L in your mock portfolio yet.
OPKO Health is currently unprofitable, as reflected by its negative EPS and negative P/E ratio. The valuation signal (P/E -7.26 on EPS of -0.18) suggests ongoing losses with no clear evidence of a near‑term earnings inflection based on the data provided. Absent signs of improving profitability or margin expansion, the financial profile leans negative for equity holders.
At $1.30, OPKO Health trades below its 200‑day moving average of $1.47, signaling a longer‑term downtrend despite a modest 1.6% gain over the last month. The RSI at 49.66 is neutral, indicating neither overbought nor oversold conditions and no strong momentum signal. Overall, the technical setup tilts mildly negative with the price still under key long‑term resistance.
Alternative data for OPKO Health is mixed: app downloads are surprisingly strong, but web traffic and social media growth are modest and hiring has declined. The sharp drop in job openings may indicate cost control or a lack of aggressive expansion. Overall, these signals do not yet point clearly toward strong growth or severe deterioration, resulting in a neutral read.
Combining negative earnings, a stock price below its 200‑day moving average, and only mixed alternative data, the overall picture for OPKO Health leans bearish. While strong app download activity is a notable positive signal, it is not yet supported by profitability or a convincing technical reversal. Until there is clearer evidence of sustained earnings improvement or a break above key technical levels, the risk‑reward profile appears skewed to the downside.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: